Friday, April 26, 2024 4/26/2024

Stem cell-based tissue engineering for myotendinous junction modeling and repair

Award Number: R01AR077191
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY/ABSTRACT Myotendinous junctions are the direct interface between muscle and tendon and the affected site in traumatic muscle injury and myotendinous rupture. Given the inconsistent effectiveness of existing treatments for myotendinous injuries, we propose developing an alternative approach using human induced pluripotent stem cells (iPSCs). Such cells have the capacity to create progenitor cells that can contribute to muscle and tendon regeneration. Our specific goals of this study are to engineer iPSC-derived muscle-tendon units and evaluate their utility as an in vitro model to study myotendinous junction formation, and to repair damages in muscle, tendon, and myotendinous junctions. The fundamental hypothesis guiding this proposal is that iPSC-derived musculoskeletal progenitor cells (skeletal muscle progenitor cells and tendon progenitor cells) will interact with each other and form a muscle-tendon unit with functional myotendinous junctions. This hypothesis is supported by our published studies and preliminary data demonstrating the feasibility of producing human musculoskeletal tissues from iPSCs. In this proposal, we will prepare lines of human tendon progenitor cells (hTPCs) from iPSCs. The established cells will be co-cultured with iPSC-derived skeletal muscle progenitor cells (hSMPCs) using newly featured cell culture systems for iPSCs, two-dimensional micropatterned culture platforms (Aim 1). Topographical and molecular guidance from the micropatterns can simulate cellular and molecular complexity in musculoskeletal development and pathology. Next, we will create three-dimensional muscle-tendon tissue cultures using iPSC-derived musculoskeletal progenitor cells and analyze their anatomical and physiological properties to extend the utility of iPSCs for modeling myotendinous junction formation (Aim 2). Throughout the development of these 3D culture models, we hope to identify the roles of exogenous stimulations such as signaling molecules and mechanical loads for muscle-tendon differentiation and myotendinous junction formation. Lastly, we will test the capacity of iPSC-derived muscle-tendon tissues to regenerate injured muscle, tendon, and myotendinous junctions by studying implantation in a rat model of complete myotendinous junction rupture (Aim 3). These aims will provide highly novel insights into effective approaches using iPSC-based in vitro modeling and treatments. As iPSCs can now be derived from human adult somatic tissues, this approach can be used to develop patient-specific, cell-based in vitro models and therapy for human disease. The results of this project will accelerate progress towards effective treatments for patients with musculoskeletal disorders. Given the lack of effective treatments for myotendinous injuries and the consequential burden it places on society, this study is both urgent and timely.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $307,890 )
2024	2024	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	5	12/29/2023	NON-COMPETING CONTINUATION	$307,890
														Subtotal = $307,890

Issue Date FY: 2023 ( Subtotal = $342,100 )
2023	2023	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	4	12/27/2022	NON-COMPETING CONTINUATION	$307,890
2023	2023	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	4	2/22/2023	NON-COMPETING CONTINUATION	$34,210
														Subtotal = $342,100

Issue Date FY: 2022 ( Subtotal = $338,679 )
2022	2022	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	3	5/25/2022	NON-COMPETING CONTINUATION	$30,789
2022	2022	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	3	1/14/2022	NON-COMPETING CONTINUATION	$307,890
														Subtotal = $338,679

Issue Date FY: 2021 ( Subtotal = $331,392 )
2021	2021	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6401	MADISON	WI	53715	DANE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	1/22/2021	NON-COMPETING CONTINUATION	$307,477
2021	2021	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6401	MADISON	WI	53715	DANE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	2	6/8/2021	NON-COMPETING CONTINUATION	$23,915
														Subtotal = $331,392

Issue Date FY: 2020 ( Subtotal = $341,000 )
2020	2020	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6401	MADISON	WI	53715	DANE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	3/16/2020	NEW	$341,000
														Subtotal = $341,000

Grand Total All Awards = $1,661,061

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Stem cell-based tissue engineering for myotendinous junction modeling and repair

Award Number: R01AR077191

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer